Targeting immune–fibroblast cell communication in heart failure

Amrute, Junedh M., Luo, Xin, Penna, Vinay, Yang, Steven, Yamawaki, Tracy, Hayat, Sikander, Bredemeyer, Andrea, Jung, In-Hyuk +28 more·2024·Nature

Cited by (270)

Items 101–200 of 270

  1. Airway basal stem cell-derived extracellular vesicles drive ECM remodeling and suppress fibroblasts activation via the miR-30a-5p/FAP axis in benign tracheal stenosis
    Lisi Luo, Junfeng Huang, Difei Chen, Huijie Yang, Yuling Deng, Yushan He, Jinsheng Lin, Ruiyue Zhao, Xinlu Wang, Zhuquan Su et al. · 2025 · Journal of Advanced Research
  2. Fibroblasts—The emerging therapeutic target of the cardiovascular system?
    S. Asselberghs, Maurice Halder, Rafael Kramann, Judith C. Sluimer · 2025 · Pharmacological Reviews
  3. Single cell atlas decodes the molecular dynamics of scar repair after human rotator cuff tear
    Yiming Qin, Guang Yang, Tao Zhang, Yuying Yang, Liyang Wan, Tao Zhang, Linfeng Wang, ZhiYu Hu, Zhu Dai, Hongkang Zhou et al. · 2026 · Bone Research
  4. The impact of inflammation, neuromodulation, and gut microbiota on developing cardiac fibrosis and hypertension
    Michał Kozdrowicki, Piotr Szczepaniak, V. F. Kyslyi, Lorenzo Carnevale, Daniela Carnevale, Giuseppe Lembo, Tomasz Jan Guzik, Tomasz P Mikolajczyk · 2026 · Cardiovascular Research
  5. Immunological control of skin development: from homeostasis to developmental pathologies
    Yutong Wei, Jing Gu, Zifan Zhao, Bin Gu · 2025 · Frontiers in Immunology
  6. Association between neutrophil-lymphocyte ratio and female breast cancer: an observational study from NHANES 2001-2018 with external validation
    Juan Xiong, Deju Zhang, Jing Wu, Peili Yang, Donghai Shi, Xiaolan Zhou, Ying Yuan, Chuntao Quan, Ni Xie · 2025 · Frontiers in Oncology
  7. Dissecting regulatory non-coding GWAS loci reveals fibroblast causal genes with pathophysiological relevance to heart failure
    Richard Gill, Daniel Lu, Ittai E. Eres, Jiamiao Lu, Jixin Cui, Chen Wang, Zhongsheng Yu, Tracy Yamawaki, Hong Zhou, Baikang Pei et al. · 2025 · Nature Communications
  8. Inhibiting RhoA Activation Via GDP-State Stabilization to Relieve Heart Failure
    Mengzhu Xue, Yingquan Liang, Zhen Yuan et al. · 2026 · Circulation Research
  9. Inactivation of AXL in Cardiac Fibroblasts Alleviates Right Ventricular Remodeling in Pulmonary Hypertension
    2025
  10. Macrophages in Cardiovascular Fibrosis: Novel Subpopulations, Molecular Mechanisms, and Therapeutic Targets
    Ran Li, Xiaohan Li, Xi Zhang, Jizhang Yu, Yuan Li, Shuan Ran, Song Wang, Zilong Luo, Jiulu Zhao, Yanglin Hao et al. · 2024 · Canadian Journal of Cardiology
  11. From Single Cells to Targetable Immune Mechanisms in Congenital Heart Disease, Ischemic Heart Disease, and Abdominal Aortic Aneurysm
    Ruijun He, Farid F. Kadyrov, Alekhya Parvathaneni, Guanhua Wu, Kory J. Lavine · 2026 · Circulation Research
  12. Advances in targeting myocardial fibrosis: integrating mechanisms and therapeutics
    Zihui Xu, Yuyan Zhao · 2026 · Frontiers in Cardiovascular Medicine
  13. Novel association of NAV3 with dilated cardiomyopathy and its role in cardiac fibrosis
    2026
  14. The Role of Inflammation and Immunity in Cardiovascular Disease: Molecular Mechanisms and Therapeutic Targets
    Jiaxiang Rong, Z P Wang, Xiaoxiao Lin, Ziwen Lei, Qianqian Huang, Hang Liu, Fei Luan, Junbo Zou, Yajun Shi · 2026 · MedComm
  15. Cardiac fibroblast heterogeneity in cardiac fibrosis implication for cell-type-specific treatment
    Kai Gu, Dongyan Song, J.H. Chen · 2026 · Frontiers in Physiology
  16. Type V collagen from macrophages regulates initial collagen assembly and alignment in post-infarcted hearts
    Xin Sun, Sarah Sigal, Maria-Alexa Cosma, Carla De Villiers, Michael Weinberger, Paul Richard Riley · 2025 · npj Regenerative Medicine
  17. Advances in cardiac cell interaction studies: Implications for heart disease treatment
    Liang Huang, Bingbing Xie, Andy Peng Xiang, Qiuling Xiang · 2025 · Cellular Signalling
  18. Temporal Dynamics in Murine Cardiac Transcriptome Following Myocardial Infarction
    2025
  19. Insights into immune cell–fibroblast communication in heart disease
    2024
  20. Assessment and applications of joint profiling of single-cell chromatin accessibility and transcriptome
    Hongfei Li, Jiechen Wang, Qing Liu, Quan Zou, Ximei Luo · 2025 · Briefings in Bioinformatics
  21. Single-cell multiomics and chromatin structure reveal gene-regulatory dynamics in heart failure
    Yang Xie, Luca Tucciarone, Elie N. Farah, Lei Chang, Qian Yang, Thirupura Sundari Shankar, Weston S. Elison, Shaina Tran, Jovina Djulamsah, Anita Lie et al. · 2026 · Science
  22. Modulation of Macrophage Polarization by Traditional Chinese Medicine in HFpEF: A Review of Mechanisms and Therapeutic Potentials
    Chunqiu Liu, Jinfeng Yuan, Peipei Cheng, Tao Yang, Qian Liu, Tianshu Li, Chuyi Li, Huiyan Qu, Hua Zhou · 2025 · Pharmaceuticals
  23. The Spectrum of Fibroblast Immune Biology
    Alberto Guarnieri, Shannon J. Turley · 2026 · Annual Review of Immunology
  24. In vivo immune engineering via mRNA therapeutics: reprogramming the post-infarction cardiac microenvironment
    Y H Liu, Liu R, Chao Meng, Li J, Kai Yang, Fuyuan Zhang, Xiao Xia, Guancheng Ye, Yulian Yuan · 2026 · Frontiers in Immunology
  25. Inhibition of integrin alpha V reduces inflammation and the transition to heart failure after pressure overload
    Clément Delacroix, Alexandra Achab Ali, Paul Alayrac, Marine Gandon-Renard, Aïcha Ben Zemzem, Charlène Jouve, Feriel Hamidou, Morgane Aubert, David A. Sassoon, Jean‐Sébastien Silvestre et al. · 2025 · Biochemical Pharmacology
  26. Intercellular chemerin-cmklr1 couples epicardial mechanosensing to fibroblasts in pressure overload
    Guowei Zeng, Xinjie Zhang, Longming Huang, Kai Luo, Xiaoyang Zhang, Bo Chen, Cong Li, Haoyu Li, Jinghao Zheng, Bozhong Shi et al. · 2026 · Nature Communications
  27. Perturb-seq uncovers pathological obstacles to direct cardiac reprogramming in vivo
    Yihong Cai, Yang Yang, Junbo Yang, Ruohan Ding, Qihan Zhang, Xin Dang, Chenxuan Li, Yang Zhao · 2026 · Cell stem cell
  28. Cross-dataset transcriptomic analyses identify a conserved ENPP2+ macrophage–fibroblast activation axis in hypertrophic cardiomyopathy
    Fanyi Huang, Mi Zhou, Yanjia Chen, Sha Hua, Yanxin Han, Yingze Fan, Qingchuan Li, Zhuoyan Sun, Ke Yang, Qiang Zhao et al. · 2026 · Briefings in Bioinformatics
  29. Research progress of bioactive compounds of Traditional Chinese medicine in the treatment of myocardial fibrosis-related signaling pathways
    2025
  30. Cardiovascular Disease Meets Cancer: Exploring the Epidemiology in China and Homotherapy Targeting Intersectional Mechanisms
    Shihan Xiang, Yujie Shan, XU Shi-hong, Jing Wang, Meng Luo, Jiaojiao Zhou, Qishan Chen · 2025 · Advanced Science
  31. Soluble ST2 drives fulminant myocarditis progression via the IGF2R–YY1 mitochondrial axis
    Yan Zhuang, Zhuo Zhang, Huihui Li, Kudusi Abuduwufuer, Donghui Zhang, Zheng Wen, Xiaoquan Rao, Chen Chen, Ingrid Fleming, Dao Wen Wang · 2026 · European Heart Journal
  32. Myeloid‐Mesenchymal Crosstalk in Lung Fibrosis
    Aritra Bhattacharyya, Preeti Yadav, Mallar Bhattacharya · 2025 · Comprehensive physiology
  33. LTBP4 deficiency inhibits NLRP3 inflammasome activation in cardiomyocytes and attenuates heart failure in male mice
    Siyu Ma, Nan Jiang, Zheng Zuo, Zhipeng Lian, Jian Wu, Jinghua Ma, Xiangxiang Wei, Yunquan He, Qi Pan, Jiayi Lin et al. · 2026 · Nature Communications
  34. Cardiac fibroblast diversity in HFpEF: states, niches, interorgan drivers and targets
    Muhammed Kiyar, Alexander Ruvantha Pinto, John F O’Sullivan, Bing Hui Wang, David M. Kaye · 2026 · Nature Reviews Cardiology
  35. Uridine-Cytidine Kinase 2 (UCK2)/Uridine-Cytidine Kinase Like 1 (UCKL1) complex exacerbates the differentiation of myocardial fibroblasts via TRIM21/Smurf2/Smad3 pathway after myocardial infarction
    2025
  36. Integrated single-cell and spatial multiomic analysis reveals widespread reactivation of developmental programs in diseased human hearts
    2025
  37. A Population-Scale Single-Cell Atlas of the Human Heart Reveals Cellular Remodeling and Cell–Cell Communication in Aging and Cardiac Disease
    Zheng Gong, Mengwei Li, Kok Siong Ang, Xi Hong Zhao, Chrishan J. A. Ramachandra, Xiaomeng Wang, Derek John Hausenloy, Yibin Wang, Yuguo Chen, Jinmiao Chen · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Myocardial Immune Niches in Homeostasis and Inflammation
    Christian Perez‐Shibayama, Nadine Cadosch, Dörthe Schmidt, Andreas J. Flammer, Frank Thomas Ruschitzka, Cristina Gil‐Cruz, Burkhard Ludewig · 2026 · Immunological Reviews
  39. An integrated resource for ischemic heart disease defines hallmarks and heterogeneity across time and space
    Tianhao Wang, Yining Hu, Wenbo Guo, Haoran Li, Menglei Wang, Bojin Chen, Hudong Bao, Meng Gao, Xiang Li, Qian Chen et al. · 2025 · Acta Pharmaceutica Sinica B
  40. Ferroptosis-driven immune remodeling in heart failure: the central role of macrophage reprogramming and impaired efferocytosis
    Haoyuan Zheng, Yanxiao Liang, Yi Tian · 2026 · Journal of Nanobiotechnology
  41. Macrophage-directed T cell recruitment augments IFN-Mediated suppression of cardiac reprogramming in vivo
    2026
  42. The cellular actors of the tumor microenvironment: a single-cell atlas perspective on specialized subtypes, coordinated networks, and immunotherapy
    Linnan Zhu, Nan Jiang, Zemin Zhang · 2026 · Immunity & Inflammation
  43. Macrophage ITGAV is dispensable for post-infarction remodeling in mice and does not mediate fibronectin responses
    2025
  44. The pro-fibrogenic role of SPP1+ macrophages in medical implant fibrosis: mechanisms and therapeutic opportunities
    Mei Yu, Jiemin Fu · 2026 · Frontiers in Immunology
  45. Epicardial Contributions to Fibro-Inflammatory Signaling in a Pkp2-Deficient Arrhythmogenic Cardiomyopathy Model
    Daniel D Han, Alan C. Brooks, Cameron D. Baker, Ronald A Dirkx, Deanne M. Mickelsen, Benjamin Fisler, Kavya Phadke, John M. Ashton, Mario Delmar, Eric M. Small · 2026 · Circulation Heart Failure
  46. The Interleukin-1 Family
    Cecília Garlanda, Irene Di Ceglie, Sébastien Jaillon · 2025 · Elsevier eBooks
  47. Mapping spatially-resolved transcriptomes in systemic sclerosis
    Zhijian Li, Aleix Rius Rigau, Wenjie Xie, Linlin Huang, Xian Shao, Yinan Li, Alexandru-Emil Matei, Wenjing Ye, Hejian Zou, Luca Pinello et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Multi-Omics and network-based exploration of potential molecular pathways in heart failure relevant to left bundle branch pacing response heterogeneity: Immune remodeling, hub gene identification, and drug repurposing hypotheses
    2026
  49. CX3CR1 + macrophages aggravate doxorubicin-induced cardiomyopathy by impairing cardiac mitophagy via the CSF1R-PARP1-IL1B axis
    Yiping Shi, Le Chen, Yuxiao Feng, Jingtao Liu, Wendi Wu, Yawei Jin, Huan Tong, Yijie Huang, Li Y, Zhaokuan Li et al. · 2026 · Autophagy
  50. Runx1 in Postn-Expressing Fibroblasts But Not Cardiomyocytes Exacerbates Adverse Cardiac Remodeling Post-Myocardial Infarction
    Kaelin A. Akins, Anooj Arkatkar, Michael A. Flinn, Natalie Sandor, Alexandra L. Purdy, Annabelle Brusacoram, Samantha K. Swift, Sydney L. Buday, Priyanka Choudhury, Miao Cui et al. · 2026 · JACC Basic to Translational Science
  51. Interleukin-8-induced tumor self-rampart spatially confines oncolytic virotherapy in glioblastoma
    2025
  52. Single cell transcriptomic landscape of adult and pediatric non-ischemic cardiomyopathy
    Hanna John J Tadros, Diwakar Turaga, Kyle D. Hope, Joseph A. Spinner, Iki A. Adachi, Xiao Li, James F. Martin · 2025 · Journal of Molecular and Cellular Cardiology
  53. Toll-like receptor 7 constrains efferocytosis in myocardial injury
    Yanqiu Lai, Suet Yen Chong, Vaarsha Nair, Wenhui Cui, Linjie Li, Shuting Liu, Xin Zhao, Liqiang Yang, Xiao Hou, Olga Zharkova et al. · 2026 · Basic Research in Cardiology
  54. Cardiac proteomic and phosphoproteomic profiling defines clinically relevant molecular subgroups in human heart failure
    Omar Hamed, Cristine J. Reitz, Uroš Kuzmanov, Shreya Gramolini, Mostin Hu, Jillian Halpern, Filio Billia, Anthony O. Gramolini · 2026 · Nature Cardiovascular Research
  55. Empagliflozin Attenuates Cardiac Fibrosis by Suppressing Fibroblast‐Mediated C‐C Motif Chemokine Ligand 2 Expression
    E. Nakai, K. Horitani, H. Ogawa, K. Wada, Yoshimitsu Yura, Kyung-Duk Min, S. Morioka, Y. Suwa, Ichiro Shiojima · 2026 · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease
  56. Epicardial extracellular vesicles modulate gene expression following ischemia-reperfusion injury in heart-on-a-chip
    Karl T. Wagner, Dawn Bannerman, Qinghua Wu, Simon Pascual‐Gil, Ian M. Fernandes, Luis Felipe Jiménez Vargas, Shuo Yan, Ramak Khosravi, Sargol Okhovatian, Dhana Abdo et al. · 2026 · Materials Today Bio
  57. TAK1 drives inflammatory fibroblast acquisition and shapes myocardial infarction responses in male mice
    Daniel C. Nguyen, Jonah Stephan, Lianay Gutierrez Luque, Robert Eli Brainard, Kenneth R. Brittian, Collin Wells, Madison S. Teer, Yania Martinez‐Ondaro, Kara R. Gouwens, Danielle T. Little et al. · 2026 · Nature Communications
  58. Macrophage Plasticity and Immune Remodeling in Ischemic Heart Failure
    Claire Xiao, Lucy MacDonald, Slava Epelman, Kory J. Lavine · 2026 · Immunological Reviews
  59. Transient Increase in Cardiomyocyte Protein O‐GlcNAcylation Enhances Susceptibility to Pressure Overload‐Induced Cardiac Remodeling
    Samuel F. Chang, Chae‐Myeong Ha, Manoja Kumar Brahma, Luke Potter, Mahima S. Reddy, Sayan Bakshi, Kerstin Preuß, Md Saimoon Rahman, Johannes K. Fischer, Caitlin A. Harrell et al. · 2026 · Journal of the American Heart Association
  60. Engineering nanoparticles that target fibroblast activation protein in cardiac fibrosis
    Chima V. Maduka, Gabriel J. Rodriguez‐Rivera, Manuela Garay‐Sarmiento, Amy R. Perry, Sara Boyd, Kendra Worthington, Mackenzie C. Obenreder, Stella Rydahl-Kim, Francis G. Spinale, Jason A. Burdick · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  61. Exercise training alleviates myocardial injury in mice with heart failure with preserved ejection fraction via the TLR4-mediated necroptosis pathway
    Jiawang Dong, Huimin Wang, Yamei Feng, Xuan Jiang, Yajuan Yin, Ermiao Zhang, Cuihua Wang, Jun Qiao Xing · 2026 · International Immunopharmacology
  62. Integrative single-cell and genetic profiling of human heart failure identifies targets for cardiomyocyte restoration
    Tore Bleckwehl, David Schumacher, Charlotte Heymanns, Sidrah Maryam, Anne-Sophie Andries, Sean Joseph Jurgens, Junedh Amrute, Konrad Hoeft, Xinyu Wu, Yuchen Liu et al. · 2025 · medRxiv
  63. RNA Therapeutics for In Vivo CAR-Macrophage: Advancing Cardiac Immunotherapy
    Soumaya Ben‐Aicha, Talia A. Shmool, Costanza Emanueli · 2025 · Circulation Research
  64. Preclinical Evaluation of 64 Cu-LNTH-1363S to Detect Cardiac FAP-Positive Fibroblasts Using PET Imaging
    2025
  65. Comparison of the value of FAPI imaging and speckle‑tracking echocardiography in assessment of right ventricular remodeling in pulmonary hypertension
    Bi-Xi Chen, Huimin Hu, Juanni Gong, Xiao-Ying Xi, Yaning Ma, Yuanhua Yang, Min-Fu Yang, Yidan Li · 2025 · BMC Medical Imaging
  66. T-cell activation and fibroblastic BMP4-Gremlin dysregulation indicate disease severity in acute myocarditis
    Joachimbauer, Anna, Perez-Shibayama, Christian, Payne, Emily, Hanka, Isabella, Stadler, Roman, Papadopoulou, Iliana, Rickli, Hans, Mäder, Micha T., Borst, Oliver, Zdanyte, Monika et al. · 2026 · medRxiv
  67. Circulating pro-angiogenic cells are preserved despite myocardial angiogenic signal deficits in HFpEF model
    Pallavi Shrivastava, Rukayat A. Raji, Abdallah Jwayyed, Huijing Xia, Marian Okon, Ifechukwude Joachim Biose · 2026 · Scientific Reports
  68. Colchicine attenuates cardiac hypertrophy by targeting the macrophage-driven Interleukin-6 suppression
    2026
  69. A reproducible computational transcriptomic framework for cell-type-resolved fibroinflammatory-AKT remodeling in human heart failure
    Yimeng Li · 2026 · Computational Biology and Chemistry
  70. Immune Pathways in Doxorubicin Cardiotoxicity: A Cardio-Immunology Perspective
    Giulia Guerra, G Bianco, Alessandra Ghigo · 2026 · JACC CardioOncology
  71. Macrophage‐Dependent Intercellular Crosstalk in Multiphenotypic Heart Failure With Preserved Ejection Fraction
    Yangyang Huang, Lingyun Luo, Xiantao Ma, Yajuan Huang, Chen Zhang, Xingjie Hao, Le Zhang, Hongling Zhu, Lei Dai, Min Liu · 2026 · Journal of the American Heart Association
  72. Reversing the pipeline: a ‘human-first’ multi-omics approach to cardiovascular discovery
    Elchanan Parnasa, Yair Rokach, Suzan Abedat, Offer Amir, Iddo Z. Ben‐Dov, Rabea Asleh · 2026 · Experimental & Molecular Medicine
  73. Cardiac Fibrosis: Mechanobiology, Epigenetics, and the Path to Precision Therapy
    Mohammad Hamouz, Raneem Y. Hammouz, Christine Caruana, Denise Micallef, Andrzej Kazimierz Bednarek, Philip Francis Dingli · 2026 · Cellular and Molecular Bioengineering
  74. CCND1 Mitigates Ischemia-Induced Pathological Cardiac Remodeling by Promoting Cardiac Monocyte–Derived Macrophage Transition to a Reparative Phenotype
    Chuhan Wang, Huian Han, Kailai Li et al. · 2026 · Circulation
  75. Cardiac involvement in parasitic infections
    2026
  76. O-GlcNAcylation in diabetic cardiac remodeling and a proposed endothelial-macrophage-fibroblast network
    2026
  77. Redox Phenotyping of the Donor Heart: A New Paradigm for Precision Heart Transplantation
    Tomasz Kamil Urbanowicz, Mariusz Kowalewski, Giuseppe Maria Raffa, Beata Krasińska, Calogera Pisano, Vincenzo Nuzzi, Mansur Rahnama, Piotr Suwalski, Zbigniew Krasiński, Ewelina Grywalska · 2026 · Antioxidants
  78. Cross-species functional transcriptomic analysis distinguishes conserved aging-niche remodeling from inflammatory fibroblast heterogeneity in cardiac aging and heart failure
    Yimeng LI · 2026 · Functional & Integrative Genomics
  79. Fibroblast MrgprX2/B2 signaling drives hypertrophic scar fibrosis
    Heng Xu, Meiying Sheng, Yuxin Jia, Yi Luo, Liyan Wu, Luxian Zhou, Z Wang, Jiawei Sun, Tianyi Shen, Liqin Zhou et al. · 2026 · Cell Reports
  80. Macrophages and the Tissue Repair Circuit: Homeostasis, Autoimmune Diseases, and Resolution-Based Therapeutic Strategies
    Kenta Mosallanejad, Cédric Hubeau, Annette Schwartz Sterman, Yunhao Tan · 2026 · Cells
  81. Embryonic Atrial Injury Programs a Distinct Substrate for Atrial Fibrillation Characterized by an Anti-Fibrotic Signature
    Fei Xin, Hua Wang, Xinyi Zhao, Xinhui Xu, Jiaheng Cao, Kaiyue Zhang, Yuanyuan Zhang, Jingjing Tian, Yangyang Jia, Changye Sun et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  82. The bidirectional genetic causality between immunocyte phenotypes and dilated cardiomyopathy: A bidirectional Mendelian randomization study
    2026
  83. Intercellular Targetable Mechanistic Interface for Cardiac Fibrosis
    Karthikeyan Thirugnanam, Ramchandran Ramani · 2026 · Fibrosis
  84. Molecular Imaging of Mechanisms of Impaired Cardiac Repair After Macrophage Depletion in Mice: A Longitudinal Multitracer Imaging Study
    2026
  85. A biomimetic mesenchymal stem cell membrane-coated nanodelivery system attenuates cardiac fibrosis by restoring mitochondrial homeostasis
    Yagang Ding, Bangde Xue, Sibin Guan, Mingkui Gao, Xinxin Sun, Qinchuan Li, Jun Liu · 2026 · International Journal of Pharmaceutics
  86. Decoding and Targeting Coordinated CDKN1A and CDKN2A Senescence Programs in ECM-Dominant Cardiovascular Pathologies
    Fu Gao, Anthony A. Fung, D Zhang, Xing Lou, Jungmin Nam, Mingyu Yang, Xiaolong Tian, Negin Farzad, Dejiang Wang, Gaocai Li et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  87. Suppression of fibroblastic activity prolongs cardiac transplant survival through targeting their ATG5 expression
    Zelai Wu, Bixian Luo, Deqiang Kong, Hongming Liu, Weixun Xie, Chengyu Hu, Jun He, Dong Cao, Ruibin Xi, Zhonghua Shen et al. · 2026 · Journal of Thoracic and Cardiovascular Surgery
  88. Glabridin improves cardiac remodeling after myocardial infarction by activating PPARγ to regulate the ubiquitination and degradation of EGFR
    Zixuan Li, Yiran Hu, Yu Jiang · 2026 · Biology Direct
  89. Opening a New Path to Explore With Molecular Imaging: The Adrenal-Cardiac Axis!
    2026
  90. Bioinformatics Analysis and Experimental Validation of Key Genes Associated With Hypoxia and Ischemia in Myocardial Infarction
    2026
  91. Mitochondrial electron transport chain is essential for acute inflammatory stress responses in mouse fibroblasts
    Marie Mühlon, Christina Schenkl, Lukas Harder, Luca Giordano, Julian M. Voll, Christian Franke, Diana Dudziak, Torsten Doenst, Claus Ralf A., Marten Szibor · 2026 · Scientific Reports
  92. Myocardial Inflammation and Arrhythmogenic Cardiomyopathy
    2026
  93. Fighting cardiac fibrosis using the chemomechanical method
    Yunlong Huo · 2025 · Mechanobiology in Medicine
  94. Inhibiting RhoA Activation via GDP-state Stabilization to Relieve Heart Failure
    2025
  95. Unleashing innovative cross-organ fibrosis therapies by harnessing the omics revolution
    Cynthia Lebeaupin, Katelyn L. Donahue, Ken Dower, Thomas A. Wynn, Kevin M. Hart, Thomas Fabre · 2026 · JCI Insight
  96. Cellular Retinoic Acid–Binding Protein 2 Promotes Ischemia‐Induced Cardiac Fibroblast Activation and Fibrosis Through Suppression of MRE11‐RAD50‐NBS1–Mediated DNA Repair
    Zhenyang Su, Hui Shen, Jin‐Yu Sun, Xiangqing Kong, Wei Yue Sun · 2026 · Journal of the American Heart Association
  97. The molecular landscape of hypertrophic cardiomyopathy across disease stages and genotypes
    Eleonora Adami, Yuri Kim, Sean Lee Zheng, Nikolay Shvetsov, Corinna Losert, Henrike Maatz, Syndi Barish, Gabriela Venturini, Natalia López-Anguita, Qi Shi et al. · 2026 · Science Translational Medicine
  98. Altérations de l’efferocytose des macrophages induits par les cellules endothéliales : analyse des mécanismes et approche thérapeutique pour corriger la vasculopathie et la fibrose au cours de la sclérodermie systémique
    Agathe Depaire · 2024
  99. PCSK5 promotes angiogenesis and cardiac repair after myocardial infarction
    Jieyu Guo, Siyu Ma, Jinghua Ma, Ming Liu, Fei Ge, X Wang, J I N Y I Lin, Nan Jiang, Xiaoke Lin, Zhipeng Lian et al. · 2026 · Nature Communications
  100. CD248+ fibroblasts drive cardiac fibrosis by interacting with immune cells
    2025